The Microvascular Complications Study
NCT00222508 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2012-08-02
Summary
Our general aim is to determine the prevalence of diabetic microvascular complications in CFRD patients with and without fasting hyperglycemia, and to explore whether the presence of these complications is related to diabetes or CF factors. This cross-sectional study will provide pilot data for a longitudinal study of diabetes complications in CF.
Conditions
- Cystic Fibrosis Related Diabetes
Sponsors & Collaborators
-
Cystic Fibrosis Foundation
collaborator OTHER -
Vikings Children Fund
collaborator UNKNOWN -
Moran, Antoinette, M.D.
collaborator INDIV - lead OTHER
Principal Investigators
-
Antoinette Moran, MD · University of Minnesota
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-04-30
- Completion
- 2005-07-31
Countries
- United States
Study Locations
More Related Trials
-
Genetics of Insulin and Incretins in Cystic Fibrosis
NCT01852448 ·Status: RECRUITING
-
BioEnergetics and Metabolomics in Cystic Fibrosis
NCT02225899 ·Status: COMPLETED
-
Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)
NCT07102043 ·Status: NOT_YET_RECRUITING
-
EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis
NCT03650712 ·Status: COMPLETED ·Phase: NA
-
Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis
NCT00287443 ·Status: WITHDRAWN ·Phase: NA
-
Pulmonary Vascular Disease in CF
NCT04549077 ·Status: ACTIVE_NOT_RECRUITING
-
Simplification of CF-related Diabetes Screening at Home
NCT03227094 ·Status: COMPLETED ·Phase: NA
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis
NCT05229640 ·Status: WITHDRAWN ·Phase: NA
-
Cystic Fibrosis and Cognitive Function
NCT03820349 ·Status: COMPLETED
-
Glycemic Monitoring in Cystic Fibrosis
NCT02211235 ·Status: COMPLETED
-
Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)
NCT00082238 ·Status: COMPLETED ·Phase: NA
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
NCT06350149 ·Status: RECRUITING ·Phase: NA
-
Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis
NCT02992080 ·Status: COMPLETED ·Phase: NA
-
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
NCT06837181 ·Status: RECRUITING
-
Prevention of Cystic Fibrosis Diabetes
NCT00967798 ·Status: TERMINATED ·Phase: PHASE3
-
A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance.
NCT04503408 ·Status: COMPLETED
-
Investigation of Relationship Between Vascular Functions, Exercise Capacity, and Respiratory Functions in CF
NCT04259983 ·Status: COMPLETED
-
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
NCT01805713 ·Status: COMPLETED
-
Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
NCT06546943 ·Status: RECRUITING
-
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes
NCT05385211 ·Status: COMPLETED
-
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients
NCT02496780 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
NCT06560463 ·Status: RECRUITING
-
Redox Imbalance and the Development of Cystic Fibrosis Diabetes
NCT02202876 ·Status: COMPLETED ·Phase: NA
-
Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solution for Oral Glucose Tolerance Tests in Cystic Fibrosis (CF) Patients Who Are Screened for CF-related Diabetes.
NCT05377502 ·Status: UNKNOWN